Prostate Cancer

Editor's Choice

Earlier Prostate Specific Antigen Testing Suggested

The optimal use of prostate specific antigen for early detection of prostate cancer, risk stratification, and post-treatment management is the focus of an article published in the November issue of The Journal of Urology.

LATEST ARTICLES

Optimizing erectogenic outcomes during athermal robotic prostatectomy: A risk-stratified tri-zonal approach

This article describes a risk-stratified approach based on a three-zone anatomic layout to the periprostatic neural architecture and a modified athermal robotic technique for better continence and potency outcomes without compromising surgical margin rates.

Intermittent androgen deprivation therapy limits side effects, improves quality of life

Intermittent androgen deprivation with a luteinizing hormone-releasing hormone analog causes fewer side effects and preserves quality of life compared with continuous combined androgen ablation, and many patients have prolonged treatment-free intervals.

Image guidance helps enhance robotic surgery

Incorporating image guidance into robotic surgery significantly enhanced tumor resection in a series of mock procedures involving surgical phantoms

PCA3 data suggest new cutoffs, value vs. prostate-specific antigen alone

In the search for novel biomarkers for prostate cancer diagnosis, a urinary assay for prostate cancer gene 3 (PCA3) has emerged as a promising modality.

Myth of lower morbidity for laparoscopic radical prostatectomy vs. radical retropubic prostatectomy dispelled

Complications after laparoscopic radical prostatectomy demonstrates the effect of a learning curve and the benefits of improved surgical technique, but shows little difference in overall morbidity when compared with those of anatomic radical retropubic prostatectomy .